China Slows Humanoid Robot IPOs as Regulators Question Valuations | Ukraine news
A market once fueled by government support and investor excitement now faces a tougher test: proving that humanoid robots can deliver sustainable commercial value.
Chinese regulators have slowed preparations for initial public offerings by companies developing humanoid robots. They are examining whether the sector’s high valuations reflect real commercial demand and whether project revenue involving the state represents independent sales.
As noted by Reuters
One reason for this approach was the volatile debut of Unitree Robotics, a manufacturer of humanoid and quadruped robots. When the company listed on the Shanghai Stock Exchange in August, its shares rose more than fivefold, but have since fallen 55% from their peak.
According to people familiar with the situation, regulators have informally recommended slowing preparations for certain listings in the sector. One source said IPOs by humanoid robot makers had effectively been frozen. Another emphasized that there was no formal ban, but rather an industry-wide slowdown.
The China Securities Regulatory Commission did not respond to a request for comment.
Beijing is seeking to curb speculative fervor around one of the most popular investment themes without abandoning a technology that the authorities have designated a national priority.
China is promoting “embodied intelligence” – artificial-intelligence systems capable of perceiving and acting in the physical world. This has encouraged an influx of funding from private investors and local governments.
Leo Wang, a venture capitalist at Qianchuang Capital, described the current wave of investment in robotics as “campaign-style innovation” – a term used in China to describe a boom in which companies and capital move en masse into a sector backed by government policy.
In his assessment, enthusiasm for embodied AI has already surpassed the scale of previous investment waves in China’s internet and renewable-energy sectors. Industrial robot makers are shifting toward humanoid models, while startups are raising funds at increasingly higher valuations.
Some startup founders received offers from dozens of potential investors within a few weeks and skipped standard business due diligence. On the private market, valuations for some projects have already fallen by 30% to 50%.
At least six Chinese humanoid robotics companies are preparing to go public. They include Deep Robotics, X Square Robot and AgiBot. The companies did not respond to requests for comment on a possible slowdown in their plans.
Regulators scrutinize the quality of revenue
Regulators are paying particular attention to revenue generated through projects supported by local governments. These include data-collection centers, where robots are trained to perform tasks, as well as joint ventures.
According to one source, local authorities may have provided 80% to 90% of the initial investment in some of these joint ventures. Such projects generated significant revenue for certain robotics companies.
Orders from such projects help support companies’ private-market valuations and meet formal requirements for a public listing. At the same time, regulators are seeking to determine whether they demonstrate genuine demand from independent customers.
One source estimated that the valuations of some robotics companies could fall by 60% to 70% if revenue linked to data-collection centers were excluded.
There are also questions about what customers are actually buying. Shao Tianlan, chief executive of Mek-Mind Robotics, said in a post that some highly valued embodied-AI companies were generating revenue through data-collection centers, related-party transactions and other unsustainable mechanisms as they sought to go public.
Shao Tianlan declined to provide additional comment. Shares in Mek-Mind Robotics have fallen nearly 20% from the peak recorded on the day of their September 1 debut.
From broad hype to selective assessment
Tighter scrutiny does not mean Beijing is abandoning the development of humanoid robotics. Corporate executives and investors believe the focus is shifting toward robots’ actual use, order volumes and evidence that companies can turn technical demonstrations into profitable products.
Ruiyin Zhao, a senior analyst in the research division of S&P Global Market Intelligence, said investor sentiment was shifting from “broad excitement to selective rationality.” In her view, the market is increasingly examining whether companies’ real commercial value justifies their high valuations.
Regulators’ caution comes amid a recovery in fundraising by mainland Chinese companies. According to LSEG, they raised $148.9 billion through share sales and convertible offerings in 2026, 59% more than during the same period a year earlier. Technology companies accounted for 41% of that total.
A banker who works on equity offerings in Asia said investors were still willing to fund robotics companies, but were demanding more convincing evidence of real-world use, sufficient production volumes and justifiable valuations.
What practical application does this technology have? Are the robots simply dancing for people, or are they actually working in factories? The volumes do not yet match the hype.
– a banker who works on equity offerings in Asia
China’s humanoid robot market is therefore shifting from rapid capital raising toward scrutiny of real demand, revenue quality and companies’ ability to scale commercial deliveries.
